prostate cancer
p PROSTATE CANCER Stage 4 prostate cancer is in fact terminal , and number of weeks that a person could survive after detection is minimal On the study that was conducted , at the first glance , it could show that the new medication is effective , thus prolonging lives of stage 4 prostate cancer patients . The mean number of weeks in the study is higher than normal . A 1 .2 weeks difference is indeed very vital in people 's lives But if we are to look closely at the data given , it ranges from 3

to 45 weeks , and 45 weeks being the highest . Although 45 is the only figure higher that the mean (11 .02 , it has somewhat elevated the mean , and if we are to disregard 45 weeks , we would get 7 .6 as mean , lower than the normal mean . The last data (45 ) have significantly affected the mean and the standard deviation
If we are to compare the normal standard deviation to that of the study conducted , there is a 7 .82 difference , meaning in the study , more values fall outside the normal range . If we are to plot and compare to a bell graph (standard normal deviation ) the two means , one from the study and one from the normal patients , the bell graph is somewhat stretched showing huge difference and disparity of the two standard deviation
Being in the committee that would grant funds for this study , I suggest that we should extensively examine the results of the pilot study . We should look at the patient that has lived for 45 weeks after the detection of stage 4 cancer . We have to look closely if the project has indeed helped in prolonging his life or other factors have caused it like age , lifestyle , genetics , other treatment sought , etc . I believe that if we take that patient out of the picture , the study is not effective at all , therefore , not entitled for anymore grants
References
Introductory Statistics for Business and Economics Fourth Edition Thomas H . Wonnacott and Ronald J . Wonnacott , John Wiley and Sons 1990
Statistics Manual by Crow , Davis and Maxfield , Dover Press ,1960 " HYPERLINK "http /web .archive .org /web /509 /http /www .jncicancerspectrum oxfordjournals .org /cgi /statContent /cspectfstat 99 " \o "http /web .archive .org /web /509 /http /www .jncicancerspectrum .oxfordjournals .org /cgi /statContent /cspectfstat 99 " IARC Worldwide Cancer Incidence Statistics - Prostate . JNCI Cancer Spectrum HYPERLINK "http /en .wikipedia .org /wiki /Oxford_University_Press " \o "Oxford University Press " Oxford University Press (December 19 , 2001 Retrieved on 2008-10-08 through the HYPERLINK "http /en .wikipedia .org /wiki /Internet_Archive " \o "Internet Archive Internet Archive
PAGE
PAGE 1...
More Papers on study, cancer, prostate, University Press, Cancer Incidence Statistics
Customers Who Downloaded This Essay Also Viewed
Related searches on University Press, Cancer Incidence Statistics, Dover Press
- prostate reports
- sample courseworks on study
- essays on Cancer Incidence Statistics
- study analysis
- merits of cancer
- disadvantages of Cancer Incidence Statistics
- advantages and disadvantages of University Press
- Dover Press summary
- cause and effect of Cancer Incidence Statistics
- Cancer Incidence Statistics fallacies
- Cancer Incidence Statistics test
- advantages of University Press
- cancer introduction





